RD06-04

· Nanjing Bioheng Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RD06-04, covering 2026-02-03 to 2026-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RD06-04 in Patients With Active Autoimmune Diseases [EARLY_Phase 1]